ImmuProbe
Z├╝rich
About ImmuProbe
ImmuProbe develops a protein quantification system, which is characterized by both an outstanding performance at very small sample volumes as well as low acquisition and consumable costs. We designed an approach to outmatching state-of-the-art technology in terms of usability, speed, and customisability: the BoxProbe. With this system, we intend to overcome the current limitations in research studies relying on small laboratory animals, resulting in improved quality of obtained data and drastically decreasing the number of animals needed, allowing scientists to efficiently apply the principles of the three Rs (replace, refine, reduce) of animal welfare. In the long-term future, we will apply our technology to improve the present practice in infant diagnostics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Total funding: $9.9K
- Last round: Grant (Jan 2016)
- Website: immuprobe.ch
Industries & Categories
Biotechnology, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/immuprobe-2088273 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.